CVR Development
The Center for Infectious Disease Research and Policy (CIDRAP) at the University of Minnesota led CVR development, with funding from the Bill & Melinda Gates Foundation and The Rockefeller Foundation. CVR steering group and taskforce members contributed to the development of the CVR by participating in workgroup calls regarding specific topic areas and/or reviewing written drafts of one or more sections of the document.
Steering Group Members
Ralph Baric, PhD, University of North Carolina, USA
Norman Baylor, PhD, Biologics Consulting Group, USA
Bruce Gellin, MD, MPH, The Rockefeller Foundation, USA
Jennifer Gordon, PhD, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health, USA
Rosalind Hollingsworth, PhD, Bill & Melinda Gates Foundation, USA
Michael Osterholm, PhD, MPH, CIDRAP, University of Minnesota, USA
Stanley Perlman, MD, PhD, University of Iowa, USA
Helen Rees, MB BCHIR (CANTAB), MA (CANTAB), MRCGP, DCH, DSc Medicine (hc), Wits RHI, Faculty of Health Sciences, University of the Witwatersrand, South Africa
Melanie Saville, MBBS, MSc, Coalition for Epidemic Preparedness Innovations (CEPI), UK
Charlotte Weller, PhD, Wellcome Trust, UK
Taskforce Members
Galit Alter, PhD, Moderna, USA
Dan Barouch, MD, PhD, Beth Israel Deaconess Medical Center, USA
Seth Berkley, MD, Gavi, the Vaccine Alliance, Switzerland
Pamela J. Bjorkman, PhD, California Institute of Technology, USA
Luciana Borio, MD, Council on Foreign Relations, USA
Marco Cavaleri, PhD, European Medicines Agency, Netherlands
Rachel K. Chikwamba, PhD, MBA, Council for Scientific and Industrial Research, South Africa
Christopher Chiu, BMBch, PhD, Imperial College London, UK
Cheryl Cohen, MD, PhD, National Institute of Communicable Diseases; School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, South Africa
Christopher da Costa, MD, PhD, CEPI, USA
Mark B. Feinberg, MD, PhD, International AIDS Vaccine Initiative, USA
Peter B. Gilbert, PhD, Fred Hutchinson Cancer Center, USA
Jonathan Heeney, DVM, PhD, University of Cambridge, UK
Eric Karikari-Boateng, MPharm, Ghana Food and Drugs Authority, Ghana
Wayne Koff, PhD, Human Immunome Project, USA
Marion Koopmans, DVM, PhD, Erasmus University, Netherlands
Philip Krause, MD, MBA, Consultant (formerly with the US Food and Drug Administration [FDA]), USA
Teresa Lambe, PhD, Oxford University, UK
Shabir Madhi, PhD, University of the Witwatersrand, South Africa
Jason McLellan, PhD, University of Texas at Austin, USA
Helen McShane, FRCP, PhD, FMedSci, Oxford University, UK
Kayvon Modjarrad, MD, PhD, Walter Reed Army Institute of Research (during CVR development; no with Pfizer Inc.), USA
Penny Moore, PhD, University of the Witwatersrand, South Africa
Peter Openshaw, MD, PhD, Imperial College London, UK
Peter Paradiso, PhD, Paradiso Biologics Consulting, USA
Malik Peiris, MBBS, DPhil, University of Hong Kong, China
Stanley Plotkin, MD, University of Pennsylvania, USA
Gregory A. Poland, MD, MACP, FRCP (London), Mayo Vaccine Research Group; Mayo Clinic, USA
Andrew J. Pollard, MBBS, PhD, Oxford Vaccine Group, University of Oxford; NIHR Oxford Biomedical Research Center, Oxford, UK
Stacey Schultz-Cherry, PhD, St. Jude Children’s Research Hospital, USA
Biotumelo Semete-Makokotlela, PhD, South African Health Products Regulatory Authority, South Africa
Alex Sigal, PhD, African Research Institute, South Africa
Kanta Subbarao, MBBS, World Health Organization (WHO) Collaborating Centre for Reference and Research on Influenza, Peter Doherty Institute for Infection and Immunity, Australia
Eric Topol, MD, Scripps Research, USA
Linfa Wang, PhD, Duke Global Health Institute, Duke-NUS Medical School, Singapore
Daniela Weiskopf, PhD, La Jolla Institute for Immunology, USA
E. John Wherry, PhD, University of Pennsylvania, USA
Michael Worobey, DPhil, University of Arizona, USA
CIDRAP Contributing Authors
Cory Anderson, MPH, CIDRAP, University of Minnesota, USA
Richard Danila, PhD, MPH, Epidemiology Consultant, USA
Eve Lackritz, MD, CIDRAP, University of Minnesota, USA
Tabitha Leighton Kazaglis, MPH, CIDRAP, University of Minnesota, USA
Anje Mehr, MPH, CIDRAP, University of Minnesota, USA
Kristine Moore, MD, MPH, CVR Project Director, CIDRAP, University of Minnesota, USA
Julie Ostrowsky, MSc, CIDRAP, University of Minnesota, USA
Angela Ulrich, PhD, MPH, CIDRAP, University of Minnesota, USA
CIDRAP Editorial/Design Staff
Elise Holmes, MPP, CIDRAP, University of Minnesota, USA
Marty Swain, CIDRAP, University of Minnesota, USA
Jim Wappes, CIDRAP, University of Minnesota, USA
The findings and conclusions contained within are those of the authors and do not necessarily reflect the positions or policies of the Bill & Melinda Gates Foundation and The Rockefeller Foundation.